Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure
Francisco J. Blanco; Esteban Rubio-Romero; Raimon Sanmartí; César Díaz-Torné; Pablo Talavera; Jochen Dunkel; Esperanza Naredo;
Reumatol Clin. 2020;16P1:345-52
Study of the impact of the inclusion of global pain and functional capacity assessment in the definition of remission and its maintenance for rheumatoid arthritis. Aims and methodology
Alejandro Balsa; Daniel Seoane-Mato; Marta Domínguez-Álvaro; Mercedes Alperi; Virginia Ruiz-Esquide; Javier Bachiller-Corral; Federico Díaz-González;
Reumatol Clin. 2025;21:
Clinical course and flare predictors in patients with rheumatoid arthritis in low disease activity and ultrasound remission monitored by ultrasound yearly and on-demand: A prospective 2-year observation study
Takeo Abe; Masao Tamura; Kazuyuki Tsuboi; Yuko Minagawa; Kazuteru Noguchi; Chie Ogita; Teppei Hashimoto; Naoto Azuma; Kiyoshi Matsui;
Reumatol Clin. 2024;20:517-25